We excluded adrenocortical adenomas (ACAs), undetermined adrenocortical tumors, deaths unrelated to ACC, wild-type germline TP53, and all cases of living patients with an uncertain outcome (<3 y of follow-up without recurrence or free of disease). This evidence concerns the gene TP53 and adrenal cortex neoplasm.